Literature DB >> 1425077

Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis.

L J Scully1, P Karayiannis, H C Thomas.   

Abstract

A patient with acute hepatitis B developed significant polyarthritis. After 10 months of observation he had not cleared the virus and continued to have symptomatic joint problems, with migratory polyarthralgia, tenosynovitis of the left wrist, and a large knee effusion. Hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA levels were measured in the synovial fluid and were found to be virtually identical to serum levels, indicating the potential infectivity of this fluid. The patient was treated with 14 weeks of thrice-weekly lymphoblastoid interferon and cleared all markers of viral replication. The arthritis resolved with the disappearance of measurable HBsAg. Interferon may be effective therapy for this disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425077     DOI: 10.1007/bf01299871

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  [Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange].

Authors:  C Trepo; D Ouzan; J Delmont; J Tremisi
Journal:  Presse Med       Date:  1988-09-10       Impact factor: 1.228

2.  Association between hepatitis B virus and essential mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; D Zucker-Franklin; E C Franklin
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

3.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

4.  Arthritis of hepatitis associated with Australia antigen.

Authors:  D K Onion; C S Crumpacker; B C Gilliland
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

5.  The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

Authors:  E Alpert; K J Isselbacher; P H Schur
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

6.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

7.  Arthritis as the main or only symptom of hepatitis B infection.

Authors:  C Pease; A Keat
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

8.  Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.

Authors:  L J Scully; R Shein; P Karayiannis; J A McDonald; H C Thomas
Journal:  J Hepatol       Date:  1987-08       Impact factor: 25.083

9.  The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies.

Authors:  J Nagy; G Bajtai; H Brasch; T Süle; M Ambrus; G Deák; A Hámori
Journal:  Clin Nephrol       Date:  1979-09       Impact factor: 0.975

10.  Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.

Authors:  M G Brook; P Karayiannis; H C Thomas
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

View more
  5 in total

1.  Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection.

Authors:  Sang-il Lee; Wan Hee Yoo; Hee Jin Yun; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Ji An Hur; Yong Gon Cho
Journal:  Clin Rheumatol       Date:  2006-11-29       Impact factor: 3.650

2.  Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.

Authors:  Yu-Lan Chen; Jun Jing; Ying-Qian Mo; Jian-Da Ma; Li-Juan Yang; Le-Feng Chen; Xiang Zhang; Tao Yan; Dong-Hui Zheng; Frank Pessler; Lie Dai
Journal:  Arthritis Res Ther       Date:  2018-06-19       Impact factor: 5.156

3.  The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis.

Authors:  Chan-Juan Zou; Lang-Jing Zhu; Yan-Hua Li; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Xia Ou-Yang; Frank Pessler; Lie Dai
Journal:  Clin Rheumatol       Date:  2013-01-23       Impact factor: 3.650

4.  Association of Rheumatoid Arthritis and Hepatitis B Infection: A Nationwide Nested Case-Control Study From 1999 to 2009 in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; Hans Hsienhong Lin; Chien-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.

Authors:  Yu-Lan Chen; Jian-Zi Lin; Ying-Qian Mo; Jian-Da Ma; Qian-Hua Li; Xiao-Ying Wang; Ze-Hong Yang; Tao Yan; Dong-Hui Zheng; Lie Dai
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.